Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats

• Published in: Diabetology Vol. 3; no. 4; pp. 524 - 538
• Main Authors: Siboto, Angezwa, Akinnuga, Akinjide Moses, Ismail, Muhammed Bilaal, Booysen, Irvin Noel, Sibiya, Ntethelelo Hopewell, Ngubane, Phikelelani, Khathi, Andile
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.12.2022
• Subjects: fructose; liver enzymes; NAFLD; prediabetes; rhenium (V) compound; triglycerides
• ISSN: 2673-4540; 2673-4540
• DOI: 10.3390/diabetology3040040

Non-alcoholic fatty liver disease (NAFLD) is associated with prediabetes and can be treated by using a combination of metformin and dietary modification. However, people often fail to adhere to dietary modifications and become more dependent on pharmaceutical intervention, and this affects the effectiveness of the drug. In this study, we investigated the effects of rhenium (V) compound with uracil-derived ligands on liver health in diet-induced prediabetic rats in both the presence and absence of dietary modification. Prediabetic male Sprague Dawley rats were treated with the rhenium (V) compound for 12 weeks in both the presence and absence of dietary modification while monitoring fasting blood glucose levels. Antioxidant enzyme activity, inflammation markers and liver enzymes were measured together with liver glycogen and plasma triglycerides after sacrificing. The administration of rhenium (V) compound to prediabetic rats in both the presence and absence of dietary modification resulted in reduced concentrations of fasting blood glucose and triglycerides. There was also reduced liver glycogen, oxidative stress and liver enzymes while increasing antioxidant enzymes. Altogether, the rhenium (V) compound ameliorated liver injury and prevented hepatotoxicity.